This federal contract award, valued at $1,957.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566811787 DAPAGLIFLOZIN 5 MG TABLET 30S, a medication used for the treatment of diabetes.
The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a period of performance through December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
The contract award was not designated with any set-aside requirements, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for delivering the specified pharmaceutical product to support federal healthcare needs, particularly within military and veterans' healthcare systems.
Generated 3/31/25, 9:34 AM